Q32 Bio (QTTB) Change in Accured Expenses (2017 - 2026)

Q32 Bio's Change in Accured Expenses history runs 10 years deep, the most recent figure standing at -$476000.0 for Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 78.69% year-over-year to -$476000.0 in Q1 2026; TTM through Mar 2026 was -$1.6 million, a 79.69% increase from a year earlier, with the FY2025 full-year figure at -$3.3 million, up 56.86% from the prior year.
• Change in Accured Expenses slipped to -$476000.0 in Q1 2026 per QTTB's latest filing, from $306000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $6.6 million in Q2 2022 and bottomed at -$5.0 million in Q1 2022.
• The 5-year median for Change in Accured Expenses is -$889000.0 (2025), against an average of -$229470.6.
• Across the five-year window, Change in Accured Expenses soared 172.56% in 2022 and slumped 194.19% in 2024, its largest moves.
• Year by year, Change in Accured Expenses stood at $1.7 million in 2022, then jumped by 34.42% to $2.3 million in 2023, then tumbled by 143.37% to -$1.0 million in 2024, then jumped by 130.06% to $306000.0 in 2025, then sank by 255.56% to -$476000.0 in 2026.
• Per Business Quant, the three latest QTTB Change in Accured Expenses figures stand at -$476000.0 (Q1 2026), $306000.0 (Q4 2025), and -$511000.0 (Q3 2025).